These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20447650)

  • 1. A single DEX/CRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine.
    Paslakis G; Heuser I; Schweiger U; Deuschle M
    J Psychiatr Res; 2010 Dec; 44(16):1154-7. PubMed ID: 20447650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC; Huyser J; Verweij M; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Tijssen JG; Wiersinga WM; Schene AH
    Biol Psychiatry; 2006 Apr; 59(8):696-701. PubMed ID: 16368077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined dexamethasone/CRH test as a potential surrogate marker in depression.
    Ising M; Künzel HE; Binder EB; Nickel T; Modell S; Holsboer F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1085-93. PubMed ID: 15950349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T; Ising M; Erbe S; Winkelmann P; Ritter D; Uhr M; Lewitzka U
    J Psychiatr Res; 2012 Jan; 46(1):111-7. PubMed ID: 22030468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G; Derijk RH; Giltay EJ; van Vliet IM; van Pelt J; Zitman FG
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):409-15. PubMed ID: 19327969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?
    Castrogiovanni P; Blardi P; De Lalla A; Dell'Erba A; Auteri A
    Psychopharmacol Bull; 2003; 37(2):102-8. PubMed ID: 14566218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    Aubry JM; Gervasoni N; Osiek C; Perret G; Rossier MF; Bertschy G; Bondolfi G
    J Psychiatr Res; 2007; 41(3-4):290-4. PubMed ID: 16956623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C; Zill P; Baghai TC; Eser D; Zwanzger P; Wenig N; Rupprecht R; Bondy B
    Psychoneuroendocrinology; 2006 Sep; 31(8):1019-25. PubMed ID: 16890377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender based response to fluoxetine hydrochloride medication in endogenous depression.
    Bano S; Akhter S; Afridi MI
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):161-5. PubMed ID: 15228850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression.
    Pfennig A; Kunzel HE; Kern N; Ising M; Majer M; Fuchs B; Ernst G; Holsboer F; Binder EB
    Biol Psychiatry; 2005 Feb; 57(4):336-42. PubMed ID: 15705348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.
    Renshaw PF; Lafer B; Babb SM; Fava M; Stoll AL; Christensen JD; Moore CM; Yurgelun-Todd DA; Bonello CM; Pillay SS; Rothschild AJ; Nierenberg AA; Rosenbaum JF; Cohen BM
    Biol Psychiatry; 1997 Apr; 41(8):837-43. PubMed ID: 9099409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.